Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07890584) titled 'A Study of PLS240 in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis' on Oct. 16.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Pathalys Pharma
Condition:
Chronic Kidney Disease (CKD)
Secondary Hyperparathyroidism
Intervention:
Drug: PLS240
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: October 30, 2026
Target Sample Size: 56
Countries of Recruitment:
United States
To know more, visit http...